Anita Goel

At the Nanobiosym Research Institute (NBS), Goel examines the physics of life and the way nanomotors read and write information into DNA.

[1][2][3] Goel has over 80 patents worldwide and has published in journals including Nature Nanotechnology[4] and Scientific American[5] and the "Proceedings of the National Academy of Sciences (PNAS).

[8] She was invited by the late MIT President Chuck Vest to serve on the Committee on Manufacturing Innovation of the National Academy of Engineering; and on the Canadian Institute for Advanced Research (CIFAR).

[9] As the chairman and CEO of Nanobiosym Diagnostics (NBSDx), Goel oversees product design, engineering, clinical trials, regulatory approvals and manufacturing of the company's breakthrough technologies, such as the Gene-RADAR and its “apps” for personalized precision medicine, digital health and global health security.

In 2020, Barclay's Bank[10] and the Unreasonable Group selected Nanobiosym Dx amongst the “World’s Top 10 Companies solving the Global COVID Crisis” and Scientific American[11] featured her work on how mobile precision testing for COVID could safely re-open the US and global economy.